Research

The annual infusion therapy Lemtrada moves closer to approval.

How do you build relationships at home, work and in your community?

The UL hosted event focused on a range of mobility issues and novel interventions

Small trial suppressing anti-myelin immune responses shows promise 

Event open to health professionals working in MS rehabilitation

TECFIDERA (BG-12) is approved in the US

Recruiting Now

Cognitive impairment differs between primary progressive and relapsing-remitting MS

Professor Michael Hutchinson Becomes MS Ireland’s Medical Advisor

MS Research Talks in Antrim and Omagh